<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01325870</url>
  </required_header>
  <id_info>
    <org_study_id>43-0566-000</org_study_id>
    <secondary_id>2R44HL082088</secondary_id>
    <nct_id>NCT01325870</nct_id>
  </id_info>
  <brief_title>Hemodynamic Effects of Standard Cardiopulmonary Resuscitation (CPR), Active Compression Decompression CPR With an Inspiratory Impedance Device, and Standard CPR With an Intrathoracic Pressure Regulator During Out-of-hospital Cardiac Arrest</brief_title>
  <official_title>Comparison of Standard Cardiopulmonary Resuscitation Alone Versus Active Compression Decompression Cardiopulmonary Resuscitation Plus an Impedance Threshold Device Versus Standard Cardiopulmonary Resuscitation Plus an Intrathoracic Pressure Regulator on Arterial Blood Pressures During Out-of-Hospital Cardiac Arrest</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Advanced Circulatory Systems</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Advanced Circulatory Systems</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      More than 300,000 Americans experience out-of-hospital cardiac arrest annually, with overall
      survival rates averaging less than 5%. Low survival rates persist, in part, because manual
      chest compressions and ventilation, termed standard cardiopulmonary resuscitation (S-CPR), is
      an inherently inefficient process, providing less than 25% of normal blood flow to the heart
      and the brain. Hemodynamics are often compromised further by poor S-CPR techniques,
      especially inadequate chest compression and incomplete chest recoil. Active Compression
      Decompression CPR (ACD-CPR) is performed with a hand-held device that is attached to the
      patient's chest, and also includes a handle containing a metronome and force gauge to guide
      proper compression rate, depth and complete chest wall recoil. The impedance threshold device
      (ITD) is designed for rapid connection to an airway adjunct (e.g. facemask or endotracheal
      tube) and allows for positive pressure ventilation, while also impeding passive inspiratory
      gas exchange during chest wall decompression. Prior studies have shown that the combination
      of ACD-CPR + ITD enhances refilling of the heart after each compression by augmenting
      negative intrathoracic pressure during the decompression phase of CPR, resulting in improved
      cardiac and cerebral perfusion. The intrathoracic pressure regulator (ITPR) is a next
      generation inspiratory impedance therapy. The ITPR uses a regulated external vacuum source to
      lower the negative intrathoracic pressure and is therefore less dependent on the quality of
      CPR (e.g., completeness of chest wall recoil). The ITPR generates a pre-set continuous and
      controlled expiratory phase negative intrathoracic pressure that is interrupted only when
      positive pressure ventilation is needed to maintain oxygenation and provide gas exchange.

      The purpose of the study is to compare the early safety and hemodynamic effects of S-CPR,
      ACD- CPR + ITD, and S-CPR + ITPR in patients with out-of-hospital cardiac arrest.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2011</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean Systolic and Diastolic Blood Pressures</measure>
    <time_frame>during CPR (day 1)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Serious Adverse Events</measure>
    <time_frame>during the index CPR procedure (day 1), at hospital discharge, at 30 days, at three months, and at six months of follow-up</time_frame>
    <description>Serious adverse events include: death, internal thoracic and abdominal injuries, device malfunction preventing use during CPR</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean Intrathoracic Pressure (Airway Pressure)</measure>
    <time_frame>during CPR (day 1)</time_frame>
    <description>Intrathoracic pressures are reported relative to atmospheric pressure</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">48</enrollment>
  <condition>Cardiac Arrest</condition>
  <condition>Sudden Cardiac Death</condition>
  <arm_group>
    <arm_group_label>ACD-CPR +ITD</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Active Compression Decompression CPR with the ResQPRO device and ResQPOD ITD device.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>S-CPR + ITPR</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>S-CPR</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ACD-CPR</intervention_name>
    <arm_group_label>ACD-CPR +ITD</arm_group_label>
    <other_name>ResQPRO Active Compression Decompression CPR Device (Advanced Circulatory Systems, Inc., Roseville, MN)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ITPR</intervention_name>
    <description>standard CPR with use of the CirQlator intrathoracic pressure regulator (ITPR)</description>
    <arm_group_label>S-CPR + ITPR</arm_group_label>
    <other_name>CirQlator Intrathoracic Pressure Regulator (Advanced Circulatory Systems, Inc., Roseville, MN)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>S-CPR</intervention_name>
    <description>standard manual CPR</description>
    <arm_group_label>S-CPR</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Impedance Threshold Device (ITD)</intervention_name>
    <arm_group_label>ACD-CPR +ITD</arm_group_label>
    <other_name>ResQPOD 16 (Advanced Circulatory Systems, Inc)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Initial Inclusion Criteria:

          -  Subject is initially presumed or known to be 18 years of age or older;

          -  Subject presents with presumed non-traumatic, out-of-hospital cardiac arrest AND is a
             candidate for resuscitation attempt. [NOTE: the cardiac arrest may be witnessed OR
             unwitnessed];

          -  Subject has a secured cuffed advanced airway [e.g., endotracheal tube, Combitube, King
             airway].

        Final Inclusion Criteria:

          -  Subject in whom femoral arterial access was successfully established;

          -  Subject remained in cardiac arrest (undergoing CPR) at the time of hemodynamic data
             acquisition;

          -  Subject in whom at least 5 minutes of continuous hemodynamic data were able to be
             collected, OR if ROSC occurs before 5 minutes, at least 2 minutes of hemodynamic data
             were able to be collected.

        Initial Exclusion Criteria:

          -  Subject has known pre-existing DNR orders in place prior to this cardiac arrest;

          -  Subject has signs of obvious clinical death or conditions that preclude the use of
             CPR;

          -  Subject's family or legal guardians request that the subject not be entered in the
             study at the time of arrest;

          -  Subject has recent sternotomy, with wound not appearing completely healed (if date of
             sternotomy is unknown) or less than six months (if date of sternotomy is known);

          -  Subject has a stoma, tracheotomy, or tracheostomy prior to arrest;

          -  Subject is known or suspected to be pregnant;

          -  Subject is known/suspected to be a prisoner.

        Final Exclusion Criteria:

          -  Subject in whom &lt; 2 minutes of hemodynamic data were acquired while receiving CPR;

          -  Subject in whom an arterial pressure catheter was not placed or arterial pressure was
             not able to be successfully monitored;

          -  Subject is subsequently found to have had a traumatic arrest;

          -  Subject was in asystole at time of initial arrest AND remained in asystole during
             resuscitation effort AND arrest was unwitnessed or unknown if witnessed.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Keith Lurie, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Advanced Circulatory Systems</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Michigan State University- Kalamazoo Center for Medical Studies</name>
      <address>
        <city>Kalamazoo</city>
        <state>Michigan</state>
        <zip>49008</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Niemann JT. Cardiopulmonary resuscitation. N Engl J Med. 1992 Oct 8;327(15):1075-80. Review.</citation>
    <PMID>1522844</PMID>
  </reference>
  <reference>
    <citation>Duggal C, Weil MH, Gazmuri RJ, Tang W, Sun S, O'Connell F, Ali M. Regional blood flow during closed-chest cardiac resuscitation in rats. J Appl Physiol (1985). 1993 Jan;74(1):147-52.</citation>
    <PMID>8444685</PMID>
  </reference>
  <reference>
    <citation>Lurie KG, Voelckel WG, Zielinski T, McKnite S, Lindstrom P, Peterson C, Wenzel V, Lindner KH, Samniah N, Benditt D. Improving standard cardiopulmonary resuscitation with an inspiratory impedance threshold valve in a porcine model of cardiac arrest. Anesth Analg. 2001 Sep;93(3):649-55.</citation>
    <PMID>11524335</PMID>
  </reference>
  <reference>
    <citation>Langhelle A, Str√∏mme T, Sunde K, Wik L, Nicolaysen G, Steen PA. Inspiratory impedance threshold valve during CPR. Resuscitation. 2002 Jan;52(1):39-48.</citation>
    <PMID>11801347</PMID>
  </reference>
  <reference>
    <citation>Lurie KG, Coffeen P, Shultz J, McKnite S, Detloff B, Mulligan K. Improving active compression-decompression cardiopulmonary resuscitation with an inspiratory impedance valve. Circulation. 1995 Mar 15;91(6):1629-32.</citation>
    <PMID>7882467</PMID>
  </reference>
  <reference>
    <citation>Plaisance P, Lurie KG, Payen D. Inspiratory impedance during active compression-decompression cardiopulmonary resuscitation: a randomized evaluation in patients in cardiac arrest. Circulation. 2000 Mar 7;101(9):989-94.</citation>
    <PMID>10704165</PMID>
  </reference>
  <reference>
    <citation>Plaisance P, Lurie KG, Vicaut E, Adnet F, Petit JL, Epain D, Ecollan P, Gruat R, Cavagna P, Biens J, Payen D. A comparison of standard cardiopulmonary resuscitation and active compression-decompression resuscitation for out-of-hospital cardiac arrest. French Active Compression-Decompression Cardiopulmonary Resuscitation Study Group. N Engl J Med. 1999 Aug 19;341(8):569-75.</citation>
    <PMID>10451462</PMID>
  </reference>
  <reference>
    <citation>Voelckel WG, Lurie KG, Sweeney M, McKnite S, Zielinski T, Lindstrom P, Peterson C, Wenzel V, Lindner KH. Effects of active compression-decompression cardiopulmonary resuscitation with the inspiratory threshold valve in a young porcine model of cardiac arrest. Pediatr Res. 2002 Apr;51(4):523-7.</citation>
    <PMID>11919340</PMID>
  </reference>
  <reference>
    <citation>Wolcke BB, Mauer DK, Schoefmann MF, Teichmann H, Provo TA, Lindner KH, Dick WF, Aeppli D, Lurie KG. Comparison of standard cardiopulmonary resuscitation versus the combination of active compression-decompression cardiopulmonary resuscitation and an inspiratory impedance threshold device for out-of-hospital cardiac arrest. Circulation. 2003 Nov 4;108(18):2201-5. Epub 2003 Oct 20.</citation>
    <PMID>14568898</PMID>
  </reference>
  <reference>
    <citation>Shultz JJ, Coffeen P, Sweeney M, Detloff B, Kehler C, Pineda E, Yakshe P, Adler SW, Chang M, Lurie KG. Evaluation of standard and active compression-decompression CPR in an acute human model of ventricular fibrillation. Circulation. 1994 Feb;89(2):684-93.</citation>
    <PMID>8313556</PMID>
  </reference>
  <reference>
    <citation>Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Part 2: ethical aspects of CPR and ECC. Circulation. 2000 Aug 22;102(8 Suppl):I12-21. Review.</citation>
    <PMID>10966661</PMID>
  </reference>
  <reference>
    <citation>Aufderheide TP, Pirrallo RG, Yannopoulos D, Klein JP, von Briesen C, Sparks CW, Deja KA, Conrad CJ, Kitscha DJ, Provo TA, Lurie KG. Incomplete chest wall decompression: a clinical evaluation of CPR performance by EMS personnel and assessment of alternative manual chest compression-decompression techniques. Resuscitation. 2005 Mar;64(3):353-62.</citation>
    <PMID>15733766</PMID>
  </reference>
  <reference>
    <citation>Yannopoulos D, Aufderheide TP, Gabrielli A, Beiser DG, McKnite SH, Pirrallo RG, Wigginton J, Becker L, Vanden Hoek T, Tang W, Nadkarni VM, Klein JP, Idris AH, Lurie KG. Clinical and hemodynamic comparison of 15:2 and 30:2 compression-to-ventilation ratios for cardiopulmonary resuscitation. Crit Care Med. 2006 May;34(5):1444-9.</citation>
    <PMID>16557155</PMID>
  </reference>
  <reference>
    <citation>Aufderheide TP, Pirrallo RG, Provo TA, Lurie KG. Clinical evaluation of an inspiratory impedance threshold device during standard cardiopulmonary resuscitation in patients with out-of-hospital cardiac arrest. Crit Care Med. 2005 Apr;33(4):734-40.</citation>
    <PMID>15818098</PMID>
  </reference>
  <reference>
    <citation>Lurie K, Voelckel W, Plaisance P, Zielinski T, McKnite S, Kor D, Sugiyama A, Sukhum P. Use of an inspiratory impedance threshold valve during cardiopulmonary resuscitation: a progress report. Resuscitation. 2000 May;44(3):219-30. Review.</citation>
    <PMID>10825624</PMID>
  </reference>
  <reference>
    <citation>Lurie KG, Mulligan KA, McKnite S, Detloff B, Lindstrom P, Lindner KH. Optimizing standard cardiopulmonary resuscitation with an inspiratory impedance threshold valve. Chest. 1998 Apr;113(4):1084-90.</citation>
    <PMID>9554651</PMID>
  </reference>
  <reference>
    <citation>Lurie KG, Zielinski T, McKnite S, Aufderheide T, Voelckel W. Use of an inspiratory impedance valve improves neurologically intact survival in a porcine model of ventricular fibrillation. Circulation. 2002 Jan 1;105(1):124-9.</citation>
    <PMID>11772887</PMID>
  </reference>
  <reference>
    <citation>Pirrallo RG, Aufderheide TP, Provo TA, Lurie KG. Effect of an inspiratory impedance threshold device on hemodynamics during conventional manual cardiopulmonary resuscitation. Resuscitation. 2005 Jul;66(1):13-20.</citation>
    <PMID>15993724</PMID>
  </reference>
  <reference>
    <citation>Thayne RC, Thomas DC, Neville JD, Van Dellen A. Use of an impedance threshold device improves short-term outcomes following out-of-hospital cardiac arrest. Resuscitation. 2005 Oct;67(1):103-8.</citation>
    <PMID>16150530</PMID>
  </reference>
  <reference>
    <citation>Plaisance P, Lurie KG, Vicaut E, Martin D, Gueugniaud PY, Petit JL, Payen D. Evaluation of an impedance threshold device in patients receiving active compression-decompression cardiopulmonary resuscitation for out of hospital cardiac arrest. Resuscitation. 2004 Jun;61(3):265-71.</citation>
    <PMID>15172704</PMID>
  </reference>
  <reference>
    <citation>Plaisance P, Soleil C, Lurie KG, Vicaut E, Ducros L, Payen D. Use of an inspiratory impedance threshold device on a facemask and endotracheal tube to reduce intrathoracic pressures during the decompression phase of active compression-decompression cardiopulmonary resuscitation. Crit Care Med. 2005 May;33(5):990-4.</citation>
    <PMID>15891326</PMID>
  </reference>
  <reference>
    <citation>Yannopoulos D, Nadkarni VM, McKnite SH, Rao A, Kruger K, Metzger A, Benditt DG, Lurie KG. Intrathoracic pressure regulator during continuous-chest-compression advanced cardiac resuscitation improves vital organ perfusion pressures in a porcine model of cardiac arrest. Circulation. 2005 Aug 9;112(6):803-11. Epub 2005 Aug 1.</citation>
    <PMID>16061732</PMID>
  </reference>
  <reference>
    <citation>Cohen TJ, Tucker KJ, Lurie KG, Redberg RF, Dutton JP, Dwyer KA, Schwab TM, Chin MC, Gelb AM, Scheinman MM, et al. Active compression-decompression. A new method of cardiopulmonary resuscitation. Cardiopulmonary Resuscitation Working Group. JAMA. 1992 Jun 3;267(21):2916-23.</citation>
    <PMID>1583761</PMID>
  </reference>
  <reference>
    <citation>Lurie KG, Shultz JJ, Callaham ML, Schwab TM, Gisch T, Rector T, Frascone RJ, Long L. Evaluation of active compression-decompression CPR in victims of out-of-hospital cardiac arrest. JAMA. 1994 May 11;271(18):1405-11.</citation>
    <PMID>8176802</PMID>
  </reference>
  <reference>
    <citation>ECC Committee, Subcommittees and Task Forces of the American Heart Association. 2005 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2005 Dec 13;112(24 Suppl):IV1-203. Epub 2005 Nov 28.</citation>
    <PMID>16314375</PMID>
  </reference>
  <reference>
    <citation>Yannopoulos D, Aufderheide TP, McKnite S, Kotsifas K, Charris R, Nadkarni V, Lurie KG. Hemodynamic and respiratory effects of negative tracheal pressure during CPR in pigs. Resuscitation. 2006 Jun;69(3):487-94. Epub 2006 May 5.</citation>
    <PMID>16678959</PMID>
  </reference>
  <reference>
    <citation>Yannopoulos D, McKnite S, Aufderheide TP, Sigurdsson G, Pirrallo RG, Benditt D, Lurie KG. Effects of incomplete chest wall decompression during cardiopulmonary resuscitation on coronary and cerebral perfusion pressures in a porcine model of cardiac arrest. Resuscitation. 2005 Mar;64(3):363-72.</citation>
    <PMID>15733767</PMID>
  </reference>
  <reference>
    <citation>Yannopoulos D, McKnite S, Metzger A, Lurie KG. Intrathoracic pressure regulation improves 24-hour survival in a porcine model of hypovolemic shock. Anesth Analg. 2007 Jan;104(1):157-62.</citation>
    <PMID>17179262</PMID>
  </reference>
  <reference>
    <citation>Yannopoulos D, McKnite SH, Metzger A, Lurie KG. Intrathoracic pressure regulation for intracranial pressure management in normovolemic and hypovolemic pigs. Crit Care Med. 2006 Dec;34(12 Suppl):S495-500.</citation>
    <PMID>17114984</PMID>
  </reference>
  <reference>
    <citation>Yannopoulos D, Metzger A, McKnite S, Nadkarni V, Aufderheide TP, Idris A, Dries D, Benditt DG, Lurie KG. Intrathoracic pressure regulation improves vital organ perfusion pressures in normovolemic and hypovolemic pigs. Resuscitation. 2006 Sep;70(3):445-53. Epub 2006 Aug 9.</citation>
    <PMID>16901611</PMID>
  </reference>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 28, 2011</study_first_submitted>
  <study_first_submitted_qc>March 29, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 30, 2011</study_first_posted>
  <results_first_submitted>June 18, 2014</results_first_submitted>
  <results_first_submitted_qc>July 16, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">July 17, 2014</results_first_posted>
  <last_update_submitted>July 12, 2016</last_update_submitted>
  <last_update_submitted_qc>July 12, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 12, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cardiopulmonary resuscitation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Arrest</mesh_term>
    <mesh_term>Death</mesh_term>
    <mesh_term>Out-of-Hospital Cardiac Arrest</mesh_term>
    <mesh_term>Death, Sudden, Cardiac</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>ACD-CPR +ITD</title>
          <description>ACD-CPR+ITD: includes combined treatment with the ResQPRO active compression decompression device and the ResQPOD ITD 16.0 impedance threshold device</description>
        </group>
        <group group_id="P2">
          <title>S-CPR + ITPR</title>
          <description>S-CPR + ITPR: standard CPR with use of the CirQlator intrathoracic pressure regulator (ITPR)</description>
        </group>
        <group group_id="P3">
          <title>S-CPR</title>
          <description>S-CPR: standard manual CPR</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="18"/>
                <participants group_id="P2" count="16"/>
                <participants group_id="P3" count="14"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="13"/>
                <participants group_id="P3" count="8"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>ACD-CPR +ITD</title>
          <description>ACD-CPR+ITD: includes combined treatment with the ResQPRO active compression decompression device and the ResQPOD ITD 16.0 impedance threshold device</description>
        </group>
        <group group_id="B2">
          <title>S-CPR + ITPR</title>
          <description>S-CPR + ITPR: standard CPR with use of the CirQlator intrathoracic pressure regulator (ITPR)</description>
        </group>
        <group group_id="B3">
          <title>S-CPR</title>
          <description>S-CPR: standard manual CPR</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="18"/>
            <count group_id="B2" value="16"/>
            <count group_id="B3" value="14"/>
            <count group_id="B4" value="48"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="63.1" spread="14.6"/>
                    <measurement group_id="B2" value="66.8" spread="18.9"/>
                    <measurement group_id="B3" value="64.7" spread="14.0"/>
                    <measurement group_id="B4" value="64.8" spread="15.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="7"/>
                    <measurement group_id="B4" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="7"/>
                    <measurement group_id="B4" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="5"/>
                    <measurement group_id="B4" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="9"/>
                    <measurement group_id="B4" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="14"/>
                    <measurement group_id="B4" value="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Mean Systolic and Diastolic Blood Pressures</title>
        <time_frame>during CPR (day 1)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ACD-CPR +ITD</title>
            <description>ACD-CPR+ITD: includes combined treatment with the ResQPRO active compression decompression device and the ResQPOD ITD 16.0 impedance threshold device</description>
          </group>
          <group group_id="O2">
            <title>S-CPR + ITPR</title>
            <description>S-CPR + ITPR: standard CPR with use of the CirQlator intrathoracic pressure regulator (ITPR)</description>
          </group>
          <group group_id="O3">
            <title>S-CPR</title>
            <description>S-CPR: standard manual CPR</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Systolic and Diastolic Blood Pressures</title>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="3"/>
                <count group_id="O3" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Systolic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80.38" spread="20.71"/>
                    <measurement group_id="O2" value="121.21" spread="22.13"/>
                    <measurement group_id="O3" value="61.37" spread="26.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diastolic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.52" spread="14.10"/>
                    <measurement group_id="O2" value="33.04" spread="24.69"/>
                    <measurement group_id="O3" value="19.29" spread="17.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Serious Adverse Events</title>
        <description>Serious adverse events include: death, internal thoracic and abdominal injuries, device malfunction preventing use during CPR</description>
        <time_frame>during the index CPR procedure (day 1), at hospital discharge, at 30 days, at three months, and at six months of follow-up</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ACD-CPR +ITD</title>
            <description>ACD-CPR+ITD: includes combined treatment with the ResQPRO active compression decompression device and the ResQPOD ITD 16.0 impedance threshold device</description>
          </group>
          <group group_id="O2">
            <title>S-CPR + ITPR</title>
            <description>S-CPR + ITPR: standard CPR with use of the CirQlator intrathoracic pressure regulator (ITPR)</description>
          </group>
          <group group_id="O3">
            <title>S-CPR</title>
            <description>S-CPR: standard manual CPR</description>
          </group>
        </group_list>
        <measure>
          <title>Serious Adverse Events</title>
          <description>Serious adverse events include: death, internal thoracic and abdominal injuries, device malfunction preventing use during CPR</description>
          <units>events</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="16"/>
                <count group_id="O3" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="9"/>
                    <measurement group_id="O3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Intrathoracic Pressure (Airway Pressure)</title>
        <description>Intrathoracic pressures are reported relative to atmospheric pressure</description>
        <time_frame>during CPR (day 1)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ACD-CPR +ITD</title>
            <description>ACD-CPR+ITD: includes combined treatment with the ResQPRO active compression decompression device and the ResQPOD ITD 16.0 impedance threshold device</description>
          </group>
          <group group_id="O2">
            <title>S-CPR + ITPR</title>
            <description>S-CPR + ITPR: standard CPR with use of the CirQlator intrathoracic pressure regulator (ITPR)</description>
          </group>
          <group group_id="O3">
            <title>S-CPR</title>
            <description>S-CPR: standard manual CPR</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Intrathoracic Pressure (Airway Pressure)</title>
          <description>Intrathoracic pressures are reported relative to atmospheric pressure</description>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="3"/>
                <count group_id="O3" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.05" spread="2.40"/>
                    <measurement group_id="O2" value="-4.40" spread="3.25"/>
                    <measurement group_id="O3" value="1.21" spread="2.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>ACD-CPR +ITD</title>
          <description>ACD-CPR+ITD: includes combined treatment with the ResQPRO active compression decompression device and the ResQPOD ITD 16.0 impedance threshold device</description>
        </group>
        <group group_id="E2">
          <title>S-CPR + ITPR</title>
          <description>S-CPR + ITPR: standard CPR with use of the CirQlator intrathoracic pressure regulator (ITPR)</description>
        </group>
        <group group_id="E3">
          <title>S-CPR</title>
          <description>S-CPR: standard manual CPR</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="18"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="16"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="14"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Re-arrest</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="18"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="16"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="14"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="14"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Device failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="16"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="14"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="18"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="16"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="14"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Pulmonary edema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="14"/>
              </event>
              <event>
                <sub_title>Blood in advanced airway</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="14"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="14"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Blood in advanced airway</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="14"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Clinical Research Associate</name_or_title>
      <organization>Advanced Circulatory</organization>
      <phone>651-403-5606</phone>
      <email>nburkhart@advancedcirculatory.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

